January 11, 2021

BioNTech Lifts 2021 COVID-19 Vaccine Output Target To 2 Billion Doses-Reuters

Pfizer’s partner BioNTech boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they bring new production lines on stream and as more doses can be extracted per vial. Special syringes known as low dead space syringes were instrumental in the increase, which would result in 1 billion people getting the designated two-dose regimen, BioNTech said in a presentation posted on Monday. The syringes allow the extraction of six doses from a standard vial, instead of the usual five, by avoiding unused liquid left in a syringe. Reuters, 01/11/2021